Feng Liu

Feng Liu

Company: Pfizer

Job title: Director


Using ctDNA to Guide Clinical Decision Making in Phase I Oncology Trials 2:30 pm

ctDNA can be more useful than tumor tissue in identification or screening patients ctDNA can be a PD biomarker as well early indicator of clinical efficacy Longitudinal monitoring emerging tumor gene alterations in ctDNA can help understand resistance mechanisms and guide patient managementRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.